Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Parallel Group Treatment, Double-blind, 3-arm Study to Investigate the Comparative PK, Safety, Immunogenicity, and Tolerability Between AVT80 and Entyvio® in Healthy Male and Female Participants Aged 18 to 55 Years Inclusive

NCT06732804 is registered in ClinicalTrials.gov with Alvotech Swiss AG as lead sponsor.

NCT NCT06732804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06732804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Parallel Group Treatment, Double-blind, 3-arm Study to Investigate the Comparative PK, Safety, Immunogenicity, and Tolerability Between AVT80 and Entyvio® in Healthy Male and Female Participants Aged 18 to 55 Years Inclusive
Lead sponsor
Alvotech Swiss AG
Phase
Phase 1
Overall status
Completed
Start date
February 11, 2025
Completion date
January 8, 2026
Enrollment
385 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

healthy male and female subjects